Tetanus, Diphtheria, Pertussis

- DT: pediatric (< age 7
years) preparation of diphtheria and tetanus toxoids.

- DTaP: pediatric preparation of diphtheria, tetanus toxoid, and acellular pertussis.

- DTP (also known as DTwP): pediatric preparation of diphtheria, tetanus toxoid, and whole cell pertussis (no longer available in the U.S.).

- Td: 7 years and older preparation of tetanus toxoid and diphtheria toxoid.

- Tdap: adolescent and older preparation of tetanus toxoid, diphtheria, and acellular pertussis.

Primary series with DT, DTaP DTP or Td; booster at age 11-64 years with Tdap.

For adolescents age 11-18, at least 5 years should have elapsed since the last dose of tetanus and diphtheria toxoid-containing vaccine, prior to receiving Tdap. For adults 19-64 years, Tdap to replace a single dose of Td for booster immunization against tetanus, diphtheria, and pertussis if they received their last dose of Td > 10 years earlier. Tetanus prophylaxis in wound management: For both age groups above, patients who require a tetanus toxoid containing vaccine as part of wound management should receive Tdap instead of Td if they have not previously received Tdap. If Tdap is not available or was administered previously, Td should be administered. Pertussis prophylaxis: For both age groups above, intervals shorter than 10 years since the last Td may be used to protect against pertussis. Particularly in settings with increased risk from
pertussis or its complications or for those who have or who anticipate having close contact with an infant < 12 months of age (parents, childcare providers, healthcare providers), a single dose of Tdap should be administered. The benefits of using a single dose of Tdap at a shorter interval to protect against pertussis generally outweighs the risk of local and systemic reactions after
vaccination. The safety of intervals as short as 2 years between Td and Tdap are supported by studies from Canada. Routine booster dose intervals: Adults should receive decennial Td boosters, beginning 10 years after receiving Tdap, until guidance on subsequent Tdap booster doses is available.

Tdap for the decennial booster dose for all college students.

Any student in the setting of: pertussis outbreaks, close contact with infants less than 12 months of age, or wound management, as appropriate.

There is a theoretical risk of increased rates of local or systemic reactions when two diphtheria toxoid containing vaccines are
administered within a short interval (i.e., on different days). Efforts should be made to administer Tdap and tetravalent meningococcal conjugate (MCV4) vaccines simultaneously if both are indicated. If simultaneous vaccination is not feasible, Tdap and MCV4 vaccines (which contain diphtheria toxoid) can be administered in any sequence.

Polio Vaccine

-Inactive (IPV)

-Oral poliovirus (OPV)

Series of 2 doses (given at 0, 6-12 mo.) prior to college entry.  Combined hepatitis A and B vaccines may be given as a series of 3 doses (given at 0, 1-2 mo., and 6-12 mo.).

 Over 2 years, repeat every 3-5 yrs.

Meningococcal quadrivalent

Conjugate (Preferred)

Polysaccharide (Acceptable alternative if conjugate not available)

Over 2 years of age, repeat every 3-5 years

Avoid vaccinating persons who are known to have experienced Guillain-Barre (GBS) syndrome

There is a theoretical risk of increased rates of local or systemic reactions when two diphtheria toxoid-containing vaccines are administered within a short interval (i.e., on different days). Efforts should be made to administer Tdap and tetravalent meningococcal conjugate (MCV4) vaccines simultaneously if both are indicated.